Further re Grant Application


 

TIDMHML 
 
RNS Number : 9394K 
Henderson Morley PLC 
28 April 2010 
 

                                                                 28 April 2010 
 
 
                              HENDERSON MORLEY PLC 
 
                                   (AIM: HML) 
 
                          FURTHER RE GRANT APPLICATION 
 
 
The Board of Henderson Morley plc ("Henderson Morley"), the AIM quoted 
biotechnology company, announces that, following its application for Grant 
Funding from the Queensland Government funded Research Industry Partnership 
Programme ("RIPP") as announced on 5 November 2009, it has been notified by the 
Queensland Institute of Medical Research ("QIMR") that the application has been 
unsuccessful, even though it was short listed. 
 
The Cytomegalovirus Vaccine funding was not granted  due to a shortage of funds 
within RIPP despite having been recommended to the Minister of Health. 
 
Commenting, Andrew Knight, Henderson Morley's Executive Chairman, said "We 
continue to make applications for Grant funding both in the UK and Overseas and 
whilst we are disappointed not to have been successful on this occasion, we 
remain optimistic that we will receive Grant Funding in the future." 
 
 
 
                                      -END- 
 
 
 
Enquires 
 
HENDERSON MORLEY PLC 
0121 442 4600 
Andrew Knight, Chairman 
 
BISHOPSGATECOMMUNICATIONS LTD                                        0207 562 
3350 
Maxine Barnes 
Gemma O'Hara 
 
BREWIN DOLPHIN INVESTMENT BANKING                                   0113 241 
0126 
Neil Baldwin 
 
RIVINGTON STREET CORPORATE FINANCE                                 0207 562 3380 
Leo Godsall 
 
Further information on Henderson Morley plc can be accessed through the 
Company's website at www.henderson-morley.com 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 FURPGUPCCUPUUBR

Henderson Mrly. (LSE:HML)
過去株価チャート
から 5 2024 まで 6 2024